Andrew John Sneddon, Director at Amplia Therapeutics Ltd., holds 364.89K shares in Amplia Therapeutics Ltd. (Ticker: INNMF). Most recently, Andrew John Sneddon Sold $611,111 shares of Amplia Therapeutics Ltd. on Aug 08, 2017 for an estimated value of 27.50K.
What is the percentage of profitable transactions made by Andrew John Sneddon?
The percentage of profitable transactions made by Andrew John Sneddon is 60%.
What is the average return per transaction made by Andrew John Sneddon?
The average return per transaction made by Andrew John Sneddon is 86.50%.
What stocks does Andrew John Sneddon hold?
Andrew John Sneddon holds: INNMF stocks.
What was Andrew John Sneddon’s latest transaction?
Andrew John Sneddon latest transaction was an Informative Sell of $27.50K.
What was Andrew John Sneddon's most profitable transaction?
Andrew John Sneddon’s most profitable transaction was an Informative Buy of INNMF stock on March 9, 2016. The return on the trade was 331.20%.
What is Andrew John Sneddon's role in Amplia Therapeutics Ltd.?
Andrew John Sneddon's role in Amplia Therapeutics Ltd. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.